IL1B and pancreatic neoplasm: EGCG inhibited tumor growth, invasion, and metastasis implying an association of the EGCG-mediated downregulation of IL-1 with the reduction in tumor growth and the development of a malignant phenotype that might play a crucial role in oncogenesis of pancreatic cancer.